Acta Scientific Microbiology (ASMI) (ISSN: 2581-3226)

Editorial Volume 3 Issue 11

Pathogenesis and Pulmonary Pathology in SARS-CoV-2 (COVID-19) Host Cell Invasion

Attapon Cheepsattayakorn1* and Ruangrong Cheepsattayakorn2

110th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
2Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.

Received: September 21, 2020; Published: September 30, 2020


  Coronaviruses are enveloped and single-stranded ribonucleic acid (RNA) viruses of approximately 30 kb with infections of various host species. SARS-CoV-2 (COVID-19) are divided into four genera; α, β, γ and δ based on their genomic structure. Alpha and beta coronaviruses infect only mammals. SARS-CoV-2 (COVID-19), SARS-CoV and Middle-East-Respiratory-Syndrome coronavirus (MERS-CoV) are classified to β coronaviruses.





Citation: Attapon Cheepsattayakorn and Ruangrong Cheepsattayakorn. “Pathogenesis and Pulmonary Pathology in SARS-CoV-2 (COVID-19) Host Cell Invasion". Acta Scientific Microbiology 3.11 (2020): 01-02.


Acceptance rate30%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US